TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
VCEL

Vericel Corp Ord

Healthcare · Biotechnology

40.10$ -2.5% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Vericel Corp Ord (VCEL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 503 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VCEL
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
28 49 41 37 40 55 52 122 124 119 141 126 138 153 150 147 158 206 211 222 224 244 240 245 248 273 265 311 318 354 357 377 390 433 425 436 453 488 486 503
21 45 37 33 36 51 48 118 119 113 110 94 105 112 117 116 125 124 127 139 145 158 152 155 166 187 178 183 186 206 190 197 191 213 198 205 222 247 244 265
8.9 23 20 14 15 27 30 95 53 18 35 14 37 27 46 56 44 34 58 52 55 68 56 56 65 51 62 43 60 69 71 50 54 75 73 81 100 100 109 125
8.9 23 20 14 15 27 30 95 98 83 84 66 75 70 82 81 86 76 84 91 98 103 101 101 111 120 119 98 105 110 118 103 102 116 113 117 135 137 145 162
7.9 17 12 15 15 18 13 17 16 23 19 21 20 32 24 24 26 35 29 32 29 37 32 34 34 47 38 38 40 58 50 48 48 61 53 64 60 85 72 76
3.6 3.5 4.0 3.2 4.0 3.8 3.9 3.7 3.6 3.6 4.1 4.8 6.8 6.8 7.3 8.4 10 9.4 10 13 13 13 14 16 17 16 15 14 13 13 14 15 16 17 17 17 18 18 18 18
4.2 3.9 3.6 3.5 4.0 4.1 4.2 4.7 5.2 5.9 6.4 7.0 7.2 32 32 31 32 58 58 58 59 59 59 60 59 57 – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – 7.5 7.3 7.2 7.0 6.9 6.7 6.6 6.4 6.3 6.1 5.9 5.8 5.6 5.5 5.3
17 24 25 23 24 32 31 32 30 16 38 37 41 42 40 39 43 71 71 71 67 73 68 70 70 81 71 112 114 128 123 134 133 141 129 129 131 133 129 133
15 13 15 13 15 13 14 15 15 15 13 13 15 20 18 18 21 22 23 24 19 26 22 25 27 37 29 36 36 46 36 44 41 50 39 41 46 49 47 53
5.6 0.8 1.4 2.1 2.6 0.4 1.6 2.8 4.1 – 2.4 2.6 2.8 5.5 5.6 5.6 6.1 4.4 4.4 4.7 2.3 3.0 3.2 3.2 4.9 4.3 4.5 7.2 7.3 6.2 6.0 5.8 6.1 9.3 11 14 14 14 14 14
5.5 6.5 6.3 6.3 6.0 5.6 5.8 5.0 4.6 7.1 6.2 5.3 5.3 6.3 6.4 4.5 6.5 6.8 8.8 8.1 5.6 9.0 7.8 9.7 8.1 17 11 14 15 22 19 25 21 24 17 13 15 16 19 21
0.0 0.0 8.7 8.0 7.4 17 16 14 13 – 25 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
11 25 16 14 17 23 21 91 94 102 103 89 97 111 110 108 115 134 140 151 157 170 172 175 178 192 194 199 204 226 234 243 257 292 295 307 322 355 356 370
-337 -344 -353 -356 -361 -361 -369 -373 -374 -369 -372 -392 -388 -379 -383 -392 -388 -376 -379 -383 -388 -383 -390 -399 -406 -400 -407 -413 -416 -403 -407 -412 -413 -393 -404 -405 -400 -376 -383 -380
23 24 32 33 34 36 36 38 43 46 44 44 47 47 45 45 47 48 46 46 47 50 47 47 47 49 47 48 48 51 48 49 49 52 50 50 52 52 51 51

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?